Tetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viability
about
Bacterial Sphingomyelinases and Phospholipases as Virulence FactorsDecaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatisMmPPOX inhibits Mycobacterium tuberculosis lipolytic enzymes belonging to the hormone-sensitive lipase family and alters mycobacterial growthElucidation and chemical modulation of sulfolipid-1 biosynthesis in Mycobacterium tuberculosis.Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.Identification of residues involved in substrate specificity and cytotoxicity of two closely related cutinases from Mycobacterium tuberculosisAdherence and invasive properties of Corynebacterium diphtheriae strains correlates with the predicted membrane-associated and secreted proteomeSystematic Survey of Serine Hydrolase Activity in Mycobacterium tuberculosis Defines Changes Associated with PersistenceEffects of Lipid-Lowering Drugs on Vancomycin Susceptibility of MycobacteriaStructural Basis for the Strict Substrate Selectivity of the Mycobacterial Hydrolase LipW.Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase.
P2860
Q26745804-ECE659C4-E75D-4B43-81D7-5DA23B8D5293Q28477097-7F7D5933-9139-4B90-A793-B90CEC596AEDQ28484106-D851ABF9-6C1A-4EF2-B320-C244772A8AA0Q34242596-CA67A40E-8A67-46FD-9576-8C7E395B0AB8Q34279501-4DC17271-4C41-4B26-964C-F5E47481D652Q34812287-4E357340-FD3D-410C-B24F-AE2FE610072CQ35802119-51362A08-B1E5-4CDB-B9D5-60DD0D535D83Q36716635-44DECF01-1DF6-451B-A7A5-CB8099153E67Q37287716-2585B138-028D-4E44-A7CF-CC9CF67CE6FDQ40415989-9712A301-DA4E-4275-89F4-096B53AFBDA5Q47753457-5641612A-7CCA-43B3-9050-1D564EC4B280
P2860
Tetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viability
description
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2010
@ast
im September 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/09/24)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/09/24)
@nl
наукова стаття, опублікована у вересні 2010
@uk
name
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@ast
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@en
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@nl
type
label
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@ast
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@en
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@nl
prefLabel
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@ast
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@en
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@nl
P2093
P2860
P50
P356
P1476
Tetrahydrolipstatin inhibition ...... al for mycobacterial viability
@en
P2093
Frances M. Chow
Julian P. Vivian
Matthew C. J. Wilce
Nicholas I. Proellocks
Rajini Brammananth
Warwick J. Britton
P2860
P304
30050–30060
P356
10.1074/JBC.M110.150094
P407
P50
P577
2010-09-24T00:00:00Z